Skeletal muscle analyses: agreement between non‐contrast and contrast CT scan measurements of skeletal muscle area and mean muscle attenuation
Open Access
- 16 April 2017
- journal article
- research article
- Published by Wiley in Clinical Physiology and Functional Imaging
- Vol. 38 (3) , 366-372
Abstract
Summary: Low skeletal muscle area (SMA) and muscle radiation attenuation (MRA) have been associated with poor prognosis in various patient populations. Both non‐contrast and contrast CT scans are used to determine SMA and MRA. The effect of the use of a contrast agent on SMA and MRA is unknown. Therefore, we investigated agreement between these two scan options. SMA and MRA of 41 healthy individuals were analysed on a paired non‐contrast and contrast single CT scan, and agreement between paired scan results was assessed with use of Bland–Altman plots, intraclass correlation coefficients (ICCs), standard error of measurements (SEM) and smallest detectable differences at a 95% confidence level (SDD95). Analyses were stratified by tube voltage. Difference in SMA between non‐contrast and contrast scans made with a different tube voltage was 7·0 ± 7·5 cm2; for scans made with the same tube voltage this was 2·3 ± 1·7 cm2. Agreement was excellent for both methods: ICC: 0·952, SEM: 7·2 cm2, SDD95: 19·9 cm2 and ICC: 0·997, SEM: 2·0 cm2, SDD95: 5·6 cm2, respectively. MRA of scans made with a different tube voltage differed 1·3 ± 11·3 HU, and agreement was poor (ICC: 0·207, SEM: 7·9 HU, SDD95: 21·8 HU). For scans made with the same tube voltage the difference was 6·7 ± 3·2 HU, and agreement was good (ICC: 0·682, SEM: 5·3 HU, SDD95: 14·6 HU). In conclusion, SMA and MRA can be slightly influenced by the use of contrast agent. To minimise measurement error, image acquisition parameters of the scans should be similar.Keywords
This publication has 24 references indexed in Scilit:
- ESPEN guidelines on definitions and terminology of clinical nutritionClinical Nutrition, 2017
- Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomesSeminars in Cell & Developmental Biology, 2016
- Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2016
- Measurement of skeletal muscle radiation attenuation and basis of its biological variationActa Physiologica, 2014
- Association of Skeletal Muscle Wasting With Treatment With Sorafenib in Patients With Advanced Renal Cell Carcinoma: Results From a Placebo-Controlled StudyJournal of Clinical Oncology, 2010
- Applying evidence on outcome measures to hand therapy practiceJournal of Hand Therapy, 2004
- Reliability of Computed Tomography Measurements of Paraspinal Muscle Cross-Sectional Area and Density in Patients With Chronic Low Back PainSpine, 2003
- Skeletal muscle low attenuation area and maximal fat oxidation rate during submaximal exercise in male obese individualsInternational Journal of Obesity, 2001
- Changes in lower limb muscle cross‐sectional area and tissue fluid volume after transition from standing to supineActa Physiologica Scandinavica, 1993
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986